ALLIANCEBERNSTEIN L.P. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$7,102,000
+486.5%
206,146
+184.3%
0.00%
+300.0%
Q2 2020$1,211,000
+15.9%
72,5000.0%0.00%0.0%
Q1 2020$1,045,000
-98.5%
72,500
-96.5%
0.00%
-97.4%
Q4 2019$69,307,000
+55.4%
2,070,715
-2.8%
0.04%
+39.3%
Q3 2019$44,608,000
+1.0%
2,130,261
+0.4%
0.03%
+3.7%
Q2 2019$44,168,000
-6.8%
2,121,399
+0.1%
0.03%
-12.9%
Q1 2019$47,370,000
+1.8%
2,119,475
+8.9%
0.03%
-11.4%
Q4 2018$46,540,000
-10.9%
1,945,670
+1.6%
0.04%
+2.9%
Q3 2018$52,260,000
+27.5%
1,915,689
+25.7%
0.03%
+17.2%
Q2 2018$40,977,000
-3.3%
1,523,871
+14.4%
0.03%
-6.5%
Q1 2018$42,396,000
-19.9%
1,331,941
-4.9%
0.03%
-18.4%
Q4 2017$52,959,000
+219.6%
1,400,281
+109.5%
0.04%
+216.7%
Q3 2017$16,568,000
+15.6%
668,354
-4.2%
0.01%
+9.1%
Q2 2017$14,338,000
-12.1%
697,392
-7.1%
0.01%
-15.4%
Q1 2017$16,311,000
+11.4%
750,640
+4.9%
0.01%
+8.3%
Q4 2016$14,637,000
+41.2%
715,727
+3.5%
0.01%
+33.3%
Q3 2016$10,369,000
+29.1%
691,242
-6.9%
0.01%
+28.6%
Q2 2016$8,031,000
-7.0%
742,217
+16.5%
0.01%0.0%
Q1 2016$8,637,000
-30.7%
636,971
-5.6%
0.01%
-36.4%
Q4 2015$12,455,000
-18.8%
675,050
+11.4%
0.01%
-15.4%
Q3 2015$15,345,000606,0290.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,300,797$90,046,00033.32%
Aisling Capital LLC 1,990,000$54,287,00011.73%
Foresite Capital Management III, LLC 801,240$21,858,0004.82%
PACIFIC VIEW ASSET MANAGEMENT, LLC 189,857$5,181,0004.12%
AlpInvest Partners B.V. 38,943$1,062,0002.27%
Eventide Asset Management 1,739,000$47,440,0001.74%
Palo Alto Investors LP 1,381,759$37,694,0001.52%
Sofinnova Investments, Inc. 222,295$6,064,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 553,000$15,086,0000.54%
EMERALD ADVISERS, LLC 486,666$13,276,0000.49%
View complete list of AIMMUNE THERAPEUTICS INC shareholders